NCT07537478 Respiration Measured Via End-tidal CO2 and Spirometry Study (RESPI)
| NCT ID | NCT07537478 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston Scientific Corporation |
| Condition | Respiration Rate Detection |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-05-28 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-05-28 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To collect respiration data via end-tidal CO2 and spirometry and compare respiration rates measured via the two methods.
Eligibility Criteria
Inclusion Criteria: * Willing and able to provide informed consent * Age 18 or above * Full time or part time BSC employee * Willing and able to participate in the required testing Exclusion Criteria: * Currently enrolled in another clinical trial that might interfere with data collection or placement of the study system * Subject is pregnant as indicated by subject report * Known allergy or sensitivity to materials used in the study (Neoprene, Nylon) * Any past or current medical event that could represent a risk for the subject to perform the study required activities in the opinion of the investigator
Contact & Investigator
Kevin Chu, PhD
PRINCIPAL INVESTIGATOR
Boston Scientific Corporation
Frequently Asked Questions
Who can join the NCT07537478 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Respiration Rate Detection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07537478 currently recruiting?
Yes, NCT07537478 is actively recruiting participants. Contact the research team at ashley.jensen@bsci.com for enrollment information.
Where is the NCT07537478 trial being conducted?
This trial is being conducted at Saint Paul, United States.
Who is sponsoring the NCT07537478 clinical trial?
NCT07537478 is sponsored by Boston Scientific Corporation. The principal investigator is Kevin Chu, PhD at Boston Scientific Corporation. The trial plans to enroll 50 participants.